SHA:688062 Revenue

In the year 2025, Mabwell (Shanghai) Bioscience had annual revenue of 662.52M CNY with 231.62% growth. Mabwell (Shanghai) Bioscience had revenue of 96.68M in the quarter ending December 31, 2025, with 64.74% growth.

Revenue

662.52M

Revenue Growth

+231.62%

P/S Ratio

20.45

Revenue / Employee

467.88K

Employees

1,362

Market Cap

13.55B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	662.52M	462.73M	231.62%
Dec 31, 2024	199.78M	71.95M	56.28%
Dec 31, 2023	127.84M	100.11M	361.03%
Dec 31, 2022	27.73M	11.50M	70.88%
Dec 31, 2021	16.23M	10.92M	206.03%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Pacific Shuanglin Bio-pharmacy	2.38B
Vcanbio Cell & Gene Engineering Corp.,	1.47B
Tibet Cheezheng Tibetan Medicine	2.42B
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	16.62B
InventisBio	37.33M
Staidson (Beijing) BioPharmaceuticals	244.37M
Inner Mongolia Furui Medical Science	1.47B
Beijing Hotgen Biotech	407.69M

Revenue Rankings